The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)
Open accessAbstract
Galectin-3 is a member of the galectin family, which are β‑galactoside‑binding lectins with ≥1 evolutionary conserved carbohydrate‑recognition domain. It binds proteins in a carbohydrate‑dependent and ‑independent manner. Galectin‑3 is predominantly located in the cytoplasm; however, it shuttles into the nucleus and is secreted onto the cell surface and into biological fluids including serum and urine. It serves important functions in numerous biological activities including cell growth, apoptosis, pre‑mRNA splicing, differentiation, transformation, angiogenesis, inflammation, fibrosis and host defense. Numerous previous studies have indicated that galectin‑3 may be used as a diagnostic or prognostic biomarker for certain types of heart disease, kidney disease and cancer. With emerging evidence to support the function and application of galectin‑3, the current review aims to summarize the latest literature regarding the biomarker characteristics and potential therapeutic application of galectin‑3 in associated diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Galectin-3: An open-ended story
Dumic, J., Dabelic, S., & Flögel, M. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.020 · Cited by 1,169
Galectin-3 – A jack-of-all-trades in cancer
Newlaczyl, A. U., & Yu, L.-G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.003 · Cited by 362
Bayes-Genis, A., de Antonio, M., Vila, J., Peñafiel, J., Galán, A., Barallat, J., Zamora, E., Urrutia, A., & Lupón, J. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.087 · Cited by 259
Galectin 3 as a guardian of the tumor microenvironment
Ruvolo, P. P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.08.008 · Cited by 224
van der Velde, A. R., Gullestad, L., Ueland, T., Aukrust, P., Guo, Y., Adourian, A., Muntendam, P., van Veldhuisen, D. J., & de Boer, R. A. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000129 · Cited by 216
The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
Calvier, L., Martinez-Martinez, E., Miana, M., Cachofeiro, V., Rousseau, E., Sádaba, J. R., Zannad, F., Rossignol, P., & López-Andrés, N. (2015) · JACC: Heart Failure · doi:10.1016/j.jchf.2014.08.002 · Cited by 215
Galectin-3 in angiogenesis and metastasis
Funasaka, T., Raz, A., & Nangia-Makker, P. (2014) · Glycobiology · doi:10.1093/glycob/cwu086 · Cited by 211
Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
Traber, P. G., & Zomer, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083481 · Cited by 208
Galectin-3 in autoimmunity and autoimmune diseases
de Oliveira, F. L., Gatto, M., Bassi, N., Luisetto, R., Ghirardello, A., Punzi, L., & Doria, A. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215593826 · Cited by 203
Delaine, T., Collins, P., MacKinnon, A., Sharma, G., Stegmayr, J., Rajput, V. K., Mandal, S., Cumpstey, I., Larumbe, A., Salameh, B. A., et al. (2016) · ChemBioChem · doi:10.1002/cbic.201600285 · Cited by 199
Cited by
Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy
Muzio, L., Viotti, A., & Martino, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.742065 · Cited by 581
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
Macrophages, Chronic Inflammation, and Insulin Resistance
Li, H., Meng, Y., He, S., Tan, X., Zhang, Y., Zhang, X., Wang, L., & Zheng, W. (2022) · Cells · doi:10.3390/cells11193001 · Cited by 264
de Charette, M., & Houot, R. (2018) · Haematologica · doi:10.3324/haematol.2017.184192 · Cited by 129
Implications of Glycosylation in Alzheimer’s Disease
Haukedal, H., & Freude, K. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.625348 · Cited by 114
Metadata
- Authors
- Dong, R., Zhang, M., Hu, Q., Zheng, S., Soh, A., Zheng, Y., & Yuan, H.
- Venue
- International Journal of Molecular Medicine
- Publisher
- Spandidos Publications
- Published
- 2017-12-05
- Volume
- 41
- Issue
- 2
- Pages
- 599-614
- ISSN
- 1107-3756 (ISSN-L)
- 1791-244X
- OpenAlex
- W2775139356
- Cited by
- 406
- References
- 102
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). https://app.cochat.ai/papers/10.3892/ijmm.2017.3311
- The paper
- Dong, R., Zhang, M., Hu, Q., Zheng, S., Soh, A., Zheng, Y., & Yuan, H. (2017). Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2017.3311
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.